Ironwood Pharmaceuticals IRWD Accrued Expenses And Other Liabilities Current
Accrued Expenses And Other Liabilities Current at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept irwd:AccruedExpensesAndOtherLiabilitiesCurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's accrued expenses and other liabilities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's accrued expenses and other liabilities current?
- Ironwood Pharmaceuticals (IRWD) reported accrued expenses and other liabilities current of $27.9M in Q1 2026.
- How has Ironwood Pharmaceuticals's accrued expenses and other liabilities current changed year-over-year?
- Ironwood Pharmaceuticals's accrued expenses and other liabilities current decreased by 16.6% year-over-year, from $33.44M to $27.9M.
- What is the long-term trend for Ironwood Pharmaceuticals's accrued expenses and other liabilities current?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's accrued expenses and other liabilities current has grown at a 4.6% compound annual growth rate (CAGR), from $26.49M to $33.24M.
- What does accrued expenses and other liabilities current mean?
- This metric captures the aggregate of short-term obligations for goods and services received but not yet settled through cash payments. It serves as a catch-all for operational accruals, including professional fees, administrative costs, and other miscellaneous current liabilities. A stable or predictable level of these accruals is generally indicative of consistent operational management.